DIN 02413825 — TEVA-VALGANCICLOVIR 450 MG
TEVA-VALGANCICLOVIR is a tablet of Valganciclovir marketed by TEVA CANADA LIMITED. The full Valganciclovir monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02413825
- Brand name
- TEVA-VALGANCICLOVIR
- Active ingredient
- Valganciclovir
- Strength
- 450 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- TEVA CANADA LIMITED
- Health Canada status
- MARKETED
- Drug class
- Antiviral agent (ganciclovir prodrug, DNA polymerase inhibitor)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Valganciclovir products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02393824 | APO-VALGANCICLOVIR | 450 MG | TABLET | APOTEX INC | DORMANT |
| 02435179 | AURO-VALGANCICLOVIR | 450 MG | TABLET | AURO PHARMA INC | MARKETED |
| 02535483 | AURO-VALGANCICLOVIR | 50 MG | POWDER FOR SOLUTION | AURO PHARMA INC | MARKETED |
| 02495457 | MINT-VALGANCICLOVIR | 450 MG | TABLET | MINT PHARMACEUTICALS INC | MARKETED |
| 02245777 | VALCYTE | 450 MG | TABLET | CHEPLAPHARM ARZNEIMITTEL GMBH | MARKETED |
| 02306085 | VALCYTE | 50 MG | POWDER FOR SOLUTION | CHEPLAPHARM ARZNEIMITTEL GMBH | MARKETED |